View post: Breville's popular $270 Nespresso machine that makes 'phenomenal' coffee is on sale for 40% off Biotech stories typically tread a very fine line between promise and pressure. Sometimes a ...
DUBLIN, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable ...
- TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of Adjusted EBITDA 1 positive operations in Q3 2025 and expects to achieve strong ...
For biotech firms, a bit of positive news—a key result from clinical trials or new drug discovery, say—can be the difference between a major rally based on a path toward sustained profitability and a ...
The data center boom has been a major economic driver in Ohio for the last few years. Still, this week, Ohio Republicans and Democrats presented different agendas for how to address some of the ...
San Diego-based Tang Capital Management bought nearly 1.2 million CELC shares. The move helped increase the fund's reported holdings in CELC by $56.8 million from quarter to quarter. It also marks a ...
A major biotech company has announced plans to lay off more than 100 positions from its Franklin, Massachusetts, facility. According to a Workers Adjustment and Retraining Notification notice, layoffs ...
Hosted on MSN
Major digital healthcare centre planned for Belfast
Belfast City Council has granted planning approval for the landmark Centre for Digital Healthcare Technology (CDHT), a major new innovation hub that will strengthen Northern Ireland’s position as a ...
The MarketWatch News Department was not involved in the creation of this content. - TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of ...
- Company also reports a key milestone of Adjusted EBITDA 1 positive operations in Q3 2025 and expects to achieve strong additional profitability growth in Q1 and Q2 2026 through continued strong ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results